Human medicines European public assessment report (EPAR): Tenofovir disoproxil Mylan, tenofovir disoproxil, Date of authorisation: 08/12/2016, Revision: 19, Status: Authorised
Opinion/decision on a Paediatric investigation plan (PIP): Veltassa, Patiromer calcium, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Other, PIP number: P/0106/2023
Human medicines European public assessment report (EPAR): Vantavo (previously Alendronate sodium and colecalciferol, MSD), alendronic acid,colecalciferol, Date of authorisation: 16/10/2009, Revision: 20, Status: Authorised
Withdrawn application: Adcetris, 23/02/2024
Quarterly System Demo – Q2 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 June 2024, 09:00 (CEST) to 26 June 2024, 13:30 (CEST)
Q&A - Quarterly System Demo Q2 2024
Human medicines European public assessment report (EPAR): Agilus, dantrolene sodium, hemiheptahydrate, Date of authorisation: 29/05/2024, Status: Authorised
CTIS newsflash - 12 July 2024
Abecma / Breyanzi / Carvykti / Kymriah / Tecartus / Yescarta
Data access to medicinal products for human use - Chapter 5 Annex A: Product data elements accessible by stakeholder group